What's Going On With Amesite Stock Thursday?
Why Amesite Stock Is Surging On Wednesday?
Amesite Stock Soars Tuesday: Everything You Need To Know
Amesite (AMST) Stock Is Trending Overnight — Here's Why It Moved Nearly 91% In After-Hours Session
Amesite Q3 EPS $(0.15) Up From $(0.16) YoY, Sales $83.332K Up From $30.690K YoY
Amesite Announces ~$600M Placement Of Common Shares, Series A-1 Warrants At $1.435/Share And Warrants
Amesite shares are trading lower after the company priced a $2 million direct offering of approximately 697,000 shares at $1.435 per share.
Amesite Announces $2M Registered Direct Offering Of 696,866 Shares At A Price Of $1.435/Share And Private Placement; To Earn Additional $4M In Potential Warrant Proceeds; Total Gross Proceeds Of Up To $6M
Amesite Shares Halted On Circuit Breaker To the Upside, Stock Now Up 87.96%
Amesite Shares Halted On Circuit Breaker To the Upside, Stock Now Up 49.07%
Amesite Files FormRW, Withdraws Securities Registration Statement; Confirms That No Securities Were Sold In Connection With The Offering Contemplated By The Registration Statement.
Amesite Enters Electronic Transactions Trading Partner Agreement With Unnamed Homecare Technology Company To Connect AI-Backed NurseMagic To Electronic Transaction Infrastructure For Electronic Visit Verification Logging Under CMS Century Cures Act
Amesite’s NurseMagic™ Named Finalist for Nurse.org “Best of Nursing: AI Nursing Tool” Award
Amesite introduces AI-native EMR system, NurseMagic EMR
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session
Amesite Accelerates Growth With Launch of AI-Native NurseMagic™ EMR
Amesite Launches AI-Native NurseMagic EMR To Expand Post-Acute Platform, Expects To Begin Onboarding Customers In January 2026
Amesite Announces 69% QoQ Revenue Increase in Q2 2026 and Product Plans for Coming Months
Amesite Reports 69% Quarterly Revenue Surge, Unveils Plan To Launch First AI-Powered Medical Record Platform For Post-Acute Care By 2026
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.